These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study. Prinster A, Quarantelli M, Orefice G, Lanzillo R, Brunetti A, Mollica C, Salvatore E, Morra VB, Coppola G, Vacca G, Alfano B, Salvatore M. Neuroimage; 2006 Feb 01; 29(3):859-67. PubMed ID: 16203159 [Abstract] [Full Text] [Related]
23. Signal abnormalities on 1.5 and 3 Tesla brain MRI in multiple sclerosis patients and healthy controls. A morphological and spatial quantitative comparison study. Di Perri C, Dwyer MG, Wack DS, Cox JL, Hashmi K, Saluste E, Hussein S, Schirda C, Stosic M, Durfee J, Poloni GU, Nayyar N, Bergamaschi R, Zivadinov R. Neuroimage; 2009 Oct 01; 47(4):1352-62. PubMed ID: 19371784 [Abstract] [Full Text] [Related]
24. Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Geurts JJ, Roosendaal SD, Calabrese M, Ciccarelli O, Agosta F, Chard DT, Gass A, Huerga E, Moraal B, Pareto D, Rocca MA, Wattjes MP, Yousry TA, Uitdehaag BM, Barkhof F, MAGNIMS Study Group. Neurology; 2011 Feb 01; 76(5):418-24. PubMed ID: 21209373 [Abstract] [Full Text] [Related]
25. Clinical correlations of brain lesion distribution in multiple sclerosis. Vellinga MM, Geurts JJ, Rostrup E, Uitdehaag BM, Polman CH, Barkhof F, Vrenken H. J Magn Reson Imaging; 2009 Apr 01; 29(4):768-73. PubMed ID: 19306365 [Abstract] [Full Text] [Related]
30. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Goretti B, Caniatti L, Di Monte E, Ferrazza P, Brescia Morra V, Lo Fermo S, Picconi O, Luccichenti G, COGIMUS Study Group. Mult Scler; 2009 Jul 15; 15(7):779-88. PubMed ID: 19542262 [Abstract] [Full Text] [Related]
31. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Bö L, Geurts JJ, van der Valk P, Polman C, Barkhof F. Arch Neurol; 2007 Jan 15; 64(1):76-80. PubMed ID: 17210812 [Abstract] [Full Text] [Related]
32. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis. Kaimen-Maciel DR, Reiche EM, Brum Souza DG, Frota Comini ER, Bobroff F, Morimoto HK, Ehara Watanabe MA, Carvalho De Oliveira J, Matsuo T, Lopes J, Donadi EA. Int J Mol Med; 2007 Sep 15; 20(3):337-44. PubMed ID: 17671738 [Abstract] [Full Text] [Related]
33. Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients. Garg N, Zivadinov R, Ramanathan M, Vasiliu I, Locke J, Watts K, Lema J, Rajeswary J, Munschauer FE, Ambrus J, Weinstock-Guttman B. J Neuroimmunol; 2007 Jul 15; 187(1-2):159-65. PubMed ID: 17512610 [Abstract] [Full Text] [Related]
37. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study. Agosta F, Absinta M, Sormani MP, Ghezzi A, Bertolotto A, Montanari E, Comi G, Filippi M. Brain; 2007 Aug 15; 130(Pt 8):2211-9. PubMed ID: 17535835 [Abstract] [Full Text] [Related]
38. [Double inversion recovery sequence in temporal lobe epilepsy: preliminary results]. Mahmutyazicioğlu K, Ozdemir H, Savranlar A, Sümer M, Atasoy T, Unal A, Gündoğdu S. Tani Girisim Radyol; 2004 Sep 15; 10(3):182-8. PubMed ID: 15470618 [Abstract] [Full Text] [Related]